Kurt Florian Thomas, MD
Neurology · Hackensack, NJNPI 1043274350
Payments from drug & device makers
Across 333 payments — averaging $110.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Greenwich Biosciences, Inc.$11K
- Genentech USA, Inc.$9K
- Sanofi$9K
- Novartis$3K
- Biogen$2K
- EMD Serono, Inc.$725
- plus $3K from 22 others
Across 4 payments — averaging $1071.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$4K
What the payments were for
- Consulting fees$16,18947%
- Speaking & faculty fees$12,67436%
- Travel & lodging$360%
- Food & beverage$5,80517%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Greenwich Biosciences, Inc. | 2 | $10,599 |
| Genentech USA, Inc. | 16 | $8,917 |
| Sanofi | 12 | $8,541 |
| Novartis | 76 | $3,305 |
| Biogen | 28 | $1,807 |
| EMD Serono, Inc. | 42 | $725 |
| Bristol Myers Squibb | 51 | $676 |
| Amgen(2 entities) | 19 | $420 |
| Teva Pharmaceuticals USA, Inc. | 21 | $291 |
| Lilly USA, LLC | 15 | $227 |
| Medtronic(2 entities) | 2 | $220 |
| Lifeward, Inc. | 1 | $165 |
| Johnson & Johnson | 13 | $157 |
| SK Life Science, Inc. | 1 | $147 |
| Lundbeck LLC | 8 | $118 |
| AbbVie(2 entities) | 6 | $91 |
| E.r. Squibb & Sons, L.L.C. | 3 | $87 |
| AstraZeneca | 4 | $74 |
| UCB, Inc. | 2 | $38 |
| Harmony Biosciences LLC | 2 | $36 |
| Merz Pharmaceuticals, LLC | 2 | $35 |
| Genentech, Inc. | 1 | $24 |
| Philips North America LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| TG Therapeutics, Inc. | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCREVUS$8,717
- AUBAGIO$8,389
- TYSABRI$150
- PERCEPT PC BRAINSENSE$128
- UPLIZNA$124
How this compares
$36,803 in reported general payments places this provider in the 80th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Glatiramer Acetate | 39 | $90,188 |
| Teriflunomide | 19 | $1,152 |
| Baclofen | 13 | $492 |
| Gabapentin | 17 | $349 |
| Pregabalin | 14 | $150 |
| Tizanidine Hcl | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other neurology in Hackensack
- Mario VukicHackensack$310K
- Subasini DashHackensack$225K
- Regina KrelHackensack$199K
- Martin GizziHackensack$197K
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Amos KatzEatontown$1.2M
- Fiona GuptaOradell$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.